Qlucore Partners with Commugene in South Korean
News Sep 19, 2014
As the world’s 12th largest economy, South Korea is one of the fastest growing and most exciting markets in the world. The recent EU-South Korea Free Trade Agreement (FTA) has resulted in the vast majority of tariffs being removed, and initiatives by the Korean Government such as Bio-Vision 2016 to step up competitiveness and improve infrastructure, has created opportunities for business.
The biotech industry is one of the fastest growing industries in Korea with an annual growth rate of 10%. South Korean publicly listed bioscience companies in 2013 registered combined revenue of $8.3 billion. Clinical trials are becoming more commonplace locally, but there is a strong demand for international partnerships to conform to global standards.
Keeping abreast with these developments, and eager to capitalize on opportunities by a global approach, Qlucore, a world leader in the development of bioinformatics software, has appointed a new agent in South Korea, Commugene.
Through the partnership with Commugene, researchers in the biotechnology industry will have easier access to Qlucore's highly intuitive software, Qlucore Omics Explorer. This data analysis tool, both extremely powerful and yet easy to use, will be invaluable for unveiling important new discoveries.
"We are delighted to be entering into this agreement with Commugene, as we are confident that this cooperation will help researchers in South Korea to learn more about our software, and to achieve extraordinary results with their data analysis." commented Carl-Johan Ivarsson, President, Qlucore.
Qlucore Omics Explorer is unique in that it allows the actual researchers - the people with the most biological insight - to study their own data and to look for patterns and structures. As a result, researchers do not need to be statistics or computer experts in order to use Qlucore Omics Explorer effectively.
"We have no doubt that Qlucore Omics Explorer will be very attractive to the scientific community in South Korea," commented Jeong-hun Kim, Director of Marketing &Sales of Commugene on the new partnership.
Kim continued, “The biotech and pharmaceutical sectors in South Korea are growing very quickly, which means that there is a strong demand for truly innovative solutions in these areas. We therefore expect to promote Qlucore’s software with great success.”
Biometric System Measures Brainwaves, Creates Brain PasswordNews
The “brain password” could have implications in banking, law enforcement, airport security and other areas.READ MORE
Cryo-EM Reveals Interaction Between Major Drug TargetsNews
For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.READ MORE
RedSeed Ventures Financially Supports the Innovative SME with 2.5 Million EuroNews
New partners are joining Pasquale Fedele, the inventor of BrainControl, who gained a total of 2.5 million Euro in a round of funding led by the Italian based investment firm RedSeed Ventures.READ MORE
Comments | 0 ADD COMMENT
International Conference on Central Nervous System and Therapeutics
Nov 12 - Nov 14, 2018